Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

170
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
170
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

336
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
336
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

297
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
297
Cancer Survival Analysis01:21

Cancer Survival Analysis

478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal mechanisms of response, resistance and relapse to teclistamab in multiple myeloma: results from MajesTEC-1.

Haematologica·2026
Same author

Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling.

Antimicrobial agents and chemotherapy·2026
Same author

Patient- and Physician-Identified Considerations for Clinical Implementation of a New Risk-Based Prediction Tool to Guide Surveillance Mammography in Breast Cancer Survivors.

JCO oncology practice·2026
Same author

Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Racial disparities and utilization trends of first-line targeted therapies for metastatic breast cancer.

JNCI cancer spectrum·2026
Same author

Trends in prevalence and incidence of diabetic retinal disease in patients with type 1 and type 2 diabetes mellitus.

Journal of diabetes and its complications·2026

Related Experiment Video

Updated: Oct 10, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

243

Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users.

Darcy E Ellis1, Rebecca A Hubbard1, Allison W Willis1,2

  • 1Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Pharmacoepidemiology and Drug Safety
|December 9, 2021
PubMed
Summary

LASSO modeling better predicts neurological side effects from fluoroquinolones than random forest. This finding is crucial for identifying patients at risk of central and peripheral nervous system dysfunction.

Keywords:
fluoroquinoloneslogistic modelsneurologic manifestationspharmacoepidemiologyregression analysissupervised machine learning

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Related Experiment Videos

Last Updated: Oct 10, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

243
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.7K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Area of Science:

  • Pharmacovigilance and Pharmacoepidemiology
  • Computational Statistics and Machine Learning
  • Clinical Risk Prediction Modeling

Background:

  • Fluoroquinolones are linked to central (CNS) and peripheral (PNS) nervous system symptoms.
  • Predicting these neurological risks is clinically significant.
  • The comparative performance of LASSO and random forest for this prediction is unclear.

Purpose of the Study:

  • To compare LASSO and random forest models for predicting neurological dysfunction in fluoroquinolone users.

Main Methods:

  • Developed and validated risk prediction models using insurance claims data.
  • Included adult fluoroquinolone users, assessing CNS and PNS dysfunction outcomes.
  • Utilized demographic, comorbidity, medication, and healthcare utilization predictors.
  • Evaluated model accuracy and calibration using AUC, calibration curves, and Brier scores.

Main Results:

  • LASSO demonstrated superior performance for CNS dysfunction (AUC 0.81) compared to random forest (AUC 0.80).
  • LASSO also outperformed random forest for PNS dysfunction (AUC 0.75 vs. 0.73).
  • LASSO models exhibited better calibration, evidenced by lower Brier scores for both CNS and PNS dysfunction.

Conclusions:

  • LASSO is a more effective method than random forest for predicting CNS and PNS dysfunction in fluoroquinolone users.
  • LASSO is recommended for modeling in modest-sized cohorts with primarily binary predictors.
  • These findings support improved clinical risk stratification for fluoroquinolone-associated neurological adverse events.